Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.26, in-line with the analyst estimate of $0.26. Revenue for the quarter came in at $197 million versus the consensus estimate of $197.8 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2022 EPS of $1.55-$1.75, versus the consensus of $1.64.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.